SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-23-012310
Filing Date
2023-02-16
Accepted
2023-02-16 10:17:35
Documents
226

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea171207-f1_altamirather.htm   iXBRL F-1 3637728
2 MEMORANDUM OF CONTINUANCE AND CORPORATE ACTIONS OF THE REGISTRANT ea171207ex3-1_altamirathe.htm EX-3.1 13209
3 BYE-LAWS OF THE REGISTRANT ea171207ex3-2_altamirathe.htm EX-3.2 30187
4 CONSENT OF DELOITTE AG ea171207ex23-1_altamirathe.htm EX-23.1 2651
5 FILING FEE TABLE ea171207ex-fee_altamirathe.htm EX-FILING FEES 16318
6 GRAPHIC image_001.jpg GRAPHIC 3994
7 GRAPHIC image_002.jpg GRAPHIC 341314
8 GRAPHIC image_003.jpg GRAPHIC 322179
9 GRAPHIC ex3-1_001.jpg GRAPHIC 120261
10 GRAPHIC ex3-1_002.jpg GRAPHIC 98312
11 GRAPHIC ex3-1_003.jpg GRAPHIC 118333
12 GRAPHIC ex3-1_004.jpg GRAPHIC 126426
13 GRAPHIC ex3-1_005.jpg GRAPHIC 121946
14 GRAPHIC ex3-1_006.jpg GRAPHIC 125173
15 GRAPHIC ex3-1_007.jpg GRAPHIC 81454
16 GRAPHIC ex3-1_008.jpg GRAPHIC 173980
17 GRAPHIC ex3-1_009.jpg GRAPHIC 109550
18 GRAPHIC ex3-1_010.jpg GRAPHIC 59818
19 GRAPHIC ex3-1_011.jpg GRAPHIC 66325
20 GRAPHIC ex3-1_012.jpg GRAPHIC 115619
21 GRAPHIC ex3-1_013.jpg GRAPHIC 100629
22 GRAPHIC ex3-1_014.jpg GRAPHIC 311855
23 GRAPHIC ex3-1_015.jpg GRAPHIC 50956
24 GRAPHIC ex3-1_016.jpg GRAPHIC 78272
25 GRAPHIC ex3-1_017.jpg GRAPHIC 147346
26 GRAPHIC ex3-1_018.jpg GRAPHIC 210367
27 GRAPHIC ex3-2_001.jpg GRAPHIC 39528
28 GRAPHIC ex3-2_002.jpg GRAPHIC 21530
29 GRAPHIC ex3-2_003.jpg GRAPHIC 101512
30 GRAPHIC ex3-2_004.jpg GRAPHIC 132504
31 GRAPHIC ex3-2_005.jpg GRAPHIC 62494
32 GRAPHIC ex3-2_006.jpg GRAPHIC 163156
33 GRAPHIC ex3-2_007.jpg GRAPHIC 193470
34 GRAPHIC ex3-2_008.jpg GRAPHIC 226321
35 GRAPHIC ex3-2_009.jpg GRAPHIC 278792
36 GRAPHIC ex3-2_010.jpg GRAPHIC 295308
37 GRAPHIC ex3-2_011.jpg GRAPHIC 247887
38 GRAPHIC ex3-2_012.jpg GRAPHIC 271285
39 GRAPHIC ex3-2_013.jpg GRAPHIC 228244
40 GRAPHIC ex3-2_014.jpg GRAPHIC 220922
41 GRAPHIC ex3-2_015.jpg GRAPHIC 244476
42 GRAPHIC ex3-2_016.jpg GRAPHIC 247444
43 GRAPHIC ex3-2_017.jpg GRAPHIC 239747
44 GRAPHIC ex3-2_018.jpg GRAPHIC 248598
45 GRAPHIC ex3-2_019.jpg GRAPHIC 236691
46 GRAPHIC ex3-2_020.jpg GRAPHIC 268090
47 GRAPHIC ex3-2_021.jpg GRAPHIC 269119
48 GRAPHIC ex3-2_022.jpg GRAPHIC 274939
49 GRAPHIC ex3-2_023.jpg GRAPHIC 247461
50 GRAPHIC ex3-2_024.jpg GRAPHIC 219519
51 GRAPHIC ex3-2_025.jpg GRAPHIC 259122
52 GRAPHIC ex3-2_026.jpg GRAPHIC 243491
53 GRAPHIC ex3-2_027.jpg GRAPHIC 251106
54 GRAPHIC ex3-2_028.jpg GRAPHIC 220384
55 GRAPHIC ex3-2_029.jpg GRAPHIC 256242
56 GRAPHIC ex3-2_030.jpg GRAPHIC 196814
57 GRAPHIC ex3-2_031.jpg GRAPHIC 305702
58 GRAPHIC ex3-2_032.jpg GRAPHIC 237372
59 GRAPHIC ex3-2_033.jpg GRAPHIC 220881
60 GRAPHIC ex3-2_034.jpg GRAPHIC 185954
61 GRAPHIC ex3-2_035.jpg GRAPHIC 214190
62 GRAPHIC ex3-2_036.jpg GRAPHIC 250406
63 GRAPHIC ex3-2_037.jpg GRAPHIC 236280
64 GRAPHIC ex3-2_038.jpg GRAPHIC 244574
65 GRAPHIC ex3-2_039.jpg GRAPHIC 260073
66 GRAPHIC ex3-2_040.jpg GRAPHIC 280454
67 GRAPHIC ex3-2_041.jpg GRAPHIC 242075
68 GRAPHIC ex3-2_042.jpg GRAPHIC 237512
  Complete submission text file 0001213900-23-012310.txt   32829794

Data Files

Seq Description Document Type Size
69 XBRL SCHEMA FILE cyto-20220630.xsd EX-101.SCH 240126
70 XBRL CALCULATION FILE cyto-20220630_cal.xml EX-101.CAL 40610
71 XBRL DEFINITION FILE cyto-20220630_def.xml EX-101.DEF 566613
72 XBRL LABEL FILE cyto-20220630_lab.xml EX-101.LAB 1160384
73 XBRL PRESENTATION FILE cyto-20220630_pre.xml EX-101.PRE 603677
220 EXTRACTED XBRL INSTANCE DOCUMENT ea171207-f1_altamirather_htm.xml XML 2632069
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-269823 | Film No.: 23637415
SIC: 2834 Pharmaceutical Preparations